Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aescin and MPFF for Acute Internal Hemorrhoids
NCT06363513Not yet recruiting
- Sponsor
- Chiang Mai University
- Start
- Apr 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of escin in Hemorrhoids (2 arms), sponsored by Chiang Mai University. Primary endpoint: Cessation of bleeding at 7 days. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
escin
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT06363513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06363513.